SMP-656 for HER2-Positive Advanced Breast Cancer

NCT07726342 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2-positive Breast Cancer
Metastatic Breast Cancer
Locally Advanced Breast Cancer (LABC)

Interventions

DRUG: SMP-656 Injection
DRUG: SMP-656 Injection

Sponsor

Chengdu SciMount Pharmatech Co., Ltd.